Cargando…

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer

The estrogen receptor is a vital receptor for therapeutic targets in estrogen receptor-positive breast cancer. The main strategy for the treatment of estrogen receptor-positive breast cancers is blocking the estrogen action on estrogen receptors by endocrine therapy but this can be restricted via en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belachew, Esmael Besufikad, Sewasew, Dareskedar Tsehay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030661/ https://www.ncbi.nlm.nih.gov/pubmed/33841325 http://dx.doi.org/10.3389/fendo.2021.599586

Ejemplares similares

Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Clinicopathological Features of Invasive Breast Cancer: A Five-Year Retrospective Study in Southern and South-Western Ethiopia
por: Belachew, Esmael Besufikad, et al.
Publicado: (2023)

The expression of matrix metalloproteinase 2, 9 and 11 in Ethiopian breast cancer patients
por: Belachew, Esmael Besufikad, et al.
Publicado: (2023)

Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia
por: Belachew, Esmael Besufikad, et al.
Publicado: (2023)

Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites
por: Belachew, Esmael Besufikad
Publicado: (2018)

Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
por: Rani, Aradhana, et al.
Publicado: (2019)

Editorial: Estrogen receptors in endocrine disorders
por: Filardi, Tiziana, et al.
Publicado: (2023)

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
por: Yuan, Jie, et al.
Publicado: (2023)

Non-canonical Estrogen Signaling in Endocrine Resistance
por: Ranganathan, Prathibha, et al.
Publicado: (2019)

ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer
por: Bond, Heather M., et al.
Publicado: (2018)

Distribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms
por: Ramírez-de-Arellano, Adrián, et al.
Publicado: (2022)

Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes
por: Lizcano, Fernando
Publicado: (2022)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
por: Zhang, Ailin, et al.
Publicado: (2021)

Estrogen-Related Receptors in Breast Cancer and Prostate Cancer
por: Misawa, Aya, et al.
Publicado: (2015)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer
por: Maximov, Philipp Y., et al.
Publicado: (2022)

Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
por: Hu, Shuying, et al.
Publicado: (2022)

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023)

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
por: Kiliti, Amber J., et al.
Publicado: (2023)

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer
por: Diaz Bessone, María Inés, et al.
Publicado: (2019)

Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer
por: Pancholi, Sunil, et al.
Publicado: (2022)

Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor
por: Souza, Deborah Simão, et al.
Publicado: (2023)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Estrogenic Pastures: A Source of Endocrine Disruption in Sheep Reproduction
por: Pool, Kelsey R., et al.
Publicado: (2022)

microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
por: Howard, Erin W., et al.
Publicado: (2018)

Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer
por: Cheung, Yee-Ming, et al.
Publicado: (2019)

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer
por: Xia, Youli, et al.
Publicado: (2022)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
por: Abderrahman, Balkees, et al.
Publicado: (2020)

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
por: Rodriguez, David, et al.
Publicado: (2019)

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
por: Nath, Aritro, et al.
Publicado: (2022)

Defects in mismatch repair: the Achilles heel of estrogen receptor positive breast cancer with intrinsic endocrine therapy resistance?
por: Haricharan, Svasti, et al.
Publicado: (2017)

27-Hydroxycholesterol, The Estrogen Receptor Modulator, Alters DNA Methylation in Breast Cancer
por: Vini, Ravindran, et al.
Publicado: (2022)

Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
por: Reinert, Tomás, et al.
Publicado: (2022)

Editorial: Resistance to Endocrine Therapies in Cancer
por: Ranganathan, Prathibha, et al.
Publicado: (2020)

Water Extract of Rhizoma Drynaria Selectively Exerts Estrogenic Activities in Ovariectomized Rats and Estrogen Receptor-Positive Cells
por: Zhou, Liping, et al.
Publicado: (2022)

Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia
por: Adugna, Adane, et al.
Publicado: (2023)

The Role of Estrogen Receptors in Urothelial Cancer
por: Goto, Takuro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4tpvmcc8tag6o4g4mjccf2f33j